Compiled all the IPOs in all Pharma & Biotech focusing on Immunology with Dermatology application in 5 years. Analyzed trends using Power BI and dashboarding to identify the top 10 trends and top 20 companies to facilitate strategic IPO planning for the client. 

Compiled data of anti-PDx molecules clinical trials from global registries and created a database using the Power BI dashboard by conducting a thorough analysis facilitating the client's selection of global trial locations with minimized competition and optimized recruitment processes. 

The study examines insulin usage among diverse diabetes patients in India through ethnographic research, focusing on daily challenges, treatment adherence, and improving patient outcomes across various demographics.

Analyzed competitor sales structures and recommended an efficient sales org structure for an EU clinical trial organization launching a Phase III molecule in the US while including salary expectations and integration into a profit and loss (P&L) analysis for strategic Go-To-Market planning.

Identified and analyzed complex small molecules in the US and EU markets based on patent expiration, profiled 60 products, and recommended 50 for generic development due to favorable sales growth projections and strategic criteria.

Analyzed top 500 global innovative biopharma companies to understand their strategies for extending small molecule products through Line of Extension (LOE) by assessing sales data, forecasting future sales, and profiling companies based on LOE development status, indications, and projected approval dates.